Phillip Burton

Retrieved on:

Wednesday, July 12, 2023

Agreement, Prejudice, Lead, Stipulation, Hearing, BioMarin Pharmaceutical, Class, Telephone, OR, The Honourable, Haemophilia, Person, Class Action, Federal Rules of Civil Procedure, Food and Drug Administration Amendments Act of 2007, District court, Settlement, Episcopal conference, Action, Motion, Leading Counsel, CLASS, Post office box, United States Senate Judiciary Subcommittee on Federal Courts, Oversight, Agency Action and Federal Rights, READ, ARE, Defendant, Phillip Burton, Summons, Claim, Counsel, III, Food, Tobacco, Insurance, Generic drug, Allocation, Notice, Court

YOU ARE ALSO NOTIFIED that Lead Plaintiff Arbejdsmarkedets Tillægspension and Defendants BioMarin, Jean-Jacques Bienaimé, and Dr. Henry Fuchs have reached a proposed settlement of the Action on behalf of the Settlement Class for $39,000,000 in cash (the "Settlement").

Key Points:

YOU ARE ALSO NOTIFIED that Lead Plaintiff Arbejdsmarkedets Tillægspension and Defendants BioMarin, Jean-Jacques Bienaimé, and Dr. Henry Fuchs have reached a proposed settlement of the Action on behalf of the Settlement Class for $39,000,000 in cash (the "Settlement").
If approved by the Court, the Settlement will resolve all claims in the Action.
If you are a member of the Settlement Class, your rights will be affected by the pending Action and the Settlement, and you may be entitled to share in the Settlement proceeds.
All questions about this notice, the Settlement, or your eligibility to participate in the Settlement should be directed to Lead Counsel or the Claims Administrator.